110 related articles for article (PubMed ID: 6495891)
1. [Kinetics of mofebutazone in plasma and synovial fluid].
Kamp J; Loew D; Barkow D; Deister J; Schuster O; Knoell HE
Z Rheumatol; 1984; 43(4):179-81. PubMed ID: 6495891
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacology, toxicology and pharmacokinetics of mofebutazone].
Loew D; Schuster O; Knoell HE; Graul EH
Z Rheumatol; 1985; 44(4):186-92. PubMed ID: 4050150
[TBL] [Abstract][Full Text] [Related]
3. [Distribution of 4-14C-mofebutazone in the rat].
Loew D; Schuster O; Graul EH
Z Rheumatol; 1986; 45(2):83-6. PubMed ID: 3727816
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of [4-14C] mofebutazone after oral administration in man.
Kassem MA; Schulte KE
Eur J Drug Metab Pharmacokinet; 1984; 9(3):223-7. PubMed ID: 6519123
[TBL] [Abstract][Full Text] [Related]
5. Transsynovial kinetics of lonazolac and its hydroxy metabolite in synovitis patients.
Deneke J; Luckow V; Guserle R; Pässler HH
Int J Clin Pharmacol Ther; 1998 Aug; 36(8):418-24. PubMed ID: 9726694
[TBL] [Abstract][Full Text] [Related]
6. [Plasma- and tissue concentrations following intramuscular administration of etofenamat. Pharmacokinetics of etofenamat and flufenamic acid in plasma, synovium, and tissues of patients with chronic polyarthritis after administration of an oily solution of etofenamat].
Köhler G; Tressel W; Dell HD; Doersing M; Fischer W; Kamp R; Langer M; Richter B; Wirzbach E
Arzneimittelforschung; 1992 Dec; 42(12):1487-91. PubMed ID: 1288513
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of lumiracoxib in plasma and synovial fluid.
Scott G; Rordorf C; Reynolds C; Kalbag J; Looby M; Milosavljev S; Weaver M; Huff JP; Ruff DA
Clin Pharmacokinet; 2004; 43(7):467-78. PubMed ID: 15139795
[TBL] [Abstract][Full Text] [Related]
8. Plasma and synovial fluid concentrations of isoxicam in meniscectomized patients.
Ballerini R; Casini A; Chinol M; Mannucci C; Melani F; Ungar F
Drugs Exp Clin Res; 1985; 11(8):517-21. PubMed ID: 3841790
[TBL] [Abstract][Full Text] [Related]
9. Stereospecific pharmacokinetics of free and protein-bound ketoprofen in serum and synovial fluid of horses after intravenous and intramuscular administration.
Brink P; DeGraves F; Ravis WR; Johansen D; Campbell JD; Duran SH
Am J Vet Res; 1998 Jun; 59(6):739-43. PubMed ID: 9622744
[TBL] [Abstract][Full Text] [Related]
10. Some observations and speculations on the factors influencing the concentration of phenylbutazone in synovial fluid.
Farr M; Hawkins CF; Kendall MJ; Willis JV
Int J Clin Pharmacol Ther Toxicol; 1982 Dec; 20(12):589-94. PubMed ID: 7152741
[TBL] [Abstract][Full Text] [Related]
11. [The tissue cage in dogs--a pharmacologic model for the representation of plasma and tissue kinetics].
Scherkl R; Hashem A; Frey HH
Dtsch Tierarztl Wochenschr; 1996 May; 103(5):174-7. PubMed ID: 8964239
[TBL] [Abstract][Full Text] [Related]
12. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
Soma LR; Uboh CE; Rudy JA; Perkowski SZ
Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
[TBL] [Abstract][Full Text] [Related]
13. Investigation of phenylbutazone in synovial fluid.
Farr M; Willis JV
J Int Med Res; 1977; 5 Suppl 2():26-9. PubMed ID: 913871
[TBL] [Abstract][Full Text] [Related]
14. Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
Chérié Lignière G; Montagnani G; Alberici M; Acerbi D
Arzneimittelforschung; 1987 May; 37(5):560-3. PubMed ID: 3619977
[TBL] [Abstract][Full Text] [Related]
15. A pharmacokinetic comparison of tenoxicam in plasma and synovial fluid.
Bird HA; Allen JG; Dixon JS; Wright V
Eur J Rheumatol Inflamm; 1985; 8(1):47-52. PubMed ID: 3879830
[TBL] [Abstract][Full Text] [Related]
16. Synovial fluid and plasma kinetics of repeat dose sustained action tiaprofenic acid in patients with rheumatoid arthritis.
Nichol FE; Samanta A; Rose CM
Drugs; 1988; 35 Suppl 1():46-51. PubMed ID: 3359945
[TBL] [Abstract][Full Text] [Related]
17. Determination of mofebutazone and its 4-hydroxy metabolite in plasma and urine by high-performance liquid chromatography.
Delbeke FT; Debackere M
J Chromatogr; 1986 Nov; 369(2):440-4. PubMed ID: 3805210
[No Abstract] [Full Text] [Related]
18. [Plasma level studies in volunteers after intramuscular injection of various doses of etofenamate in an oily solution].
Beckermann B; Bock E; Kamp R; Dell HD
Arzneimittelforschung; 1990 Mar; 40(3):305-11. PubMed ID: 2346541
[TBL] [Abstract][Full Text] [Related]
19. Disposition and tolerance of suxibuzone in horses.
Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
[TBL] [Abstract][Full Text] [Related]
20. Disposition of methylprednisolone acetate in plasma, urine, and synovial fluid following intra-articular administration to exercised thoroughbred horses.
Knych HK; Harrison LM; Casbeer HC; McKemie DS
J Vet Pharmacol Ther; 2014 Apr; 37(2):125-32. PubMed ID: 23876165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
